The effect of kinetics of C-reactive protein in the prediction of overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor-Reference-Cited by-同舟云学术

The effect of kinetics of C-reactive protein in the prediction of overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor

Published:2017-11 Issue:11 Volume:35 Page:662.e1-662.e7
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Teishima Jun^ORCID,Kobatake Kohei,Shinmei Shunsuke,Inoue Shogo,Hayashi Tetsutaro,Ohara Shinya,Mita Koji^ORCID,Hasegawa Yasuhisa,Maruyama Satoshi,Kajiwara Mitsuru,Shigeta Masanobu^ORCID,Mochizuki Hideki,Moriyama Hiroyuki,Fujiwara Seiji,Matsubara Akio

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference24 articles.

1. Cancer statistics, 2016;Siegel;CA Cancer J Clin,2016

2. The prognostic value of C-reactive protein in renal cell carcinoma: a systematic review and meta-analysis;Hu;Urol Oncol,2014

3. Change in neutrophil-to-lymphocyte ratio in response to targeted therapy for metastatic renal cell carcinoma as a prognosticator and biomarker of efficacy;Templeton;Eur Urol,2016

4. Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomy;Corcoran;BJU Int,2015

5. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma;Motzer;J Clin Oncol,2004

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of Inflammation and Progression During Immunotherapy in Patients With Metastatic Renal Cell Carcinoma;In Vivo;2023

2. Association of C-reactive protein with efficacy of avelumab plus axitinib in advanced renal cell carcinoma: long-term follow-up results from JAVELIN Renal 101;ESMO Open;2022-10

3. Impact of modified Glasgow prognostic score on predicting prognosis and modification of risk model for patients with metastatic renal cell carcinoma treated with first line tyrosine kinase inhibitor;Urologic Oncology: Seminars and Original Investigations;2022-10

4. Hematological prognosticators in metastatic renal cell cancer treated with immune checkpoint inhibitors: a meta-analysis;Immunotherapy;2022-06

5. Prediction of early progression of metastatic renal cell carcinoma treated with first-line tyrosine kinase inhibitor;Current Urology;2021-09-24